The Square Root set-up appears in large cap stocks that underwent capitulation. Because large caps are heavily traded, the high liquidity reduces sharp movements. This set-up is best for position trading and usually is a sweet spot for establishing a core position on a stock that potentially has long runway for an uptrend.
Tailwinds:
There are reasons to be optimistic for the longer-term growth with Takeda also being a diversified COVID vaccine play.
Exploring further, the company has a multi-thronged approach to the problem, first as a treatment developer undergoing clinical Phase 2 trials using plasma technology, second as a manufacturer through a license agreement with Novavax's (NASDAQ: NVAX) COVID-19 vaccine candidate and finally, as a distributor in a three-way agreement with the Japanese government for Moderna's (NASDAQ: MRNA) vaccine.